NCT03332940View on ClinicalTrials.gov

Safety Evaluation of IV Tc 99m Tilmanocept and Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASH

PHASE1TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

December 6, 2017

Primary Completion Date

March 10, 2019

Study Completion Date

March 10, 2019

Conditions
Nonalcoholic SteatohepatitisNASH - Nonalcoholic Steatohepatitis
Interventions
DRUG

Tc 99M Sulfur Colloid

Sulfur colloid is a radiotracer that is indicated for imaging areas of functional reticuloendothelial cells in the liver, spleen, and bone marrow.

DRUG

Tc99m-tilmanocept

Tilmanocept is a radiotracer that accumulates in macrophages by binding to a mannose binding receptor that resides on the surface.

Trial Locations (1)

45429

Kettering Medical Center, Kettering

Sponsors
All Listed Sponsors
lead

Navidea Biopharmaceuticals

INDUSTRY